PD-1 inhibitors are another treatment for melanoma. Nivolumab (Opdivo) and Pembrolizumab (Keytruda) are medications that attack the PD-1, which is a protein in the immune system’s cells that are most commonly referred to as T cells. These medications help the cells attack other cells within the body. By blocking the PD-1 and the way it affects the cells, this can help to boost the immune system to fight off the melanoma. It can even help to shrink the size of the tumor and even prolong the patient’s life. These medications are given through an IV (intravenously), typically on a schedule of every two to three weeks.

This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.